Stock Screener App

Frei -

Installieren

4.29

2.39% 0.10

after-market

Handel nachbörslich: 4.29

Arbutus Biopharma Corp (ABUS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	99.43% 1.014	179.13	1.051	0.529	10.74
Operating Expenses	31.71% 6.978	10.22	6.341	9.188	9.251
Operating Income/Loss	103.53% -5.964	168.91	-5.29	-8.659	1.488
Nonoperating Income/Loss	4.32% 0.821	0.787	1.534	0.917	1.035
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	103.03% -5.143	169.69	-3.756	-7.742	2.523
Basic Average Shares	1.91% 197.47	193.77	-	191.78	191.55
Diluted Average Shares	1.16% 197.47	195.21	-	191.78	192.40
Basic Earnings Per Share	103.41% -0.03	0.88	-	-0.04	0.01
Diluted Earnings Per Share	103.45% -0.03	0.87	-	-0.04	0.01

ODTX

$17.57

5.84%

ARDX

$3.27

2.51%

KURA

$9.70

0.94%

GLUE

$10.12

2.85%

VSTM

$9.23

19.71%

SLBT

$1.55

0.00%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters